PWMG
REGN icon

Private Wealth Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Private Wealth Management Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.4K Sell
60
-2
-3% -$1.36K 0.01% 266
2026
Q1 		$47.9K Buy
62
+7
+13% +$5.36K 0.01% 199
2025
Q4 		$42.5K Sell
55
-3
-5% -$2.04K 0.01% 210
2025
Q3 		$32.6K Sell
58
-1
-2% -$565 0.01% 241
2025
Q2 		$31K Buy
59
+18
+44% +$10K 0.01% 226
2025
Q1 		$26K Sell
41
-13
-24% -$8.94K 0.01% 252
2024
Q4 		$38.5K Buy
54
+39
+260% +$32.7K 0.01% 199
2024
Q3 		$15.8K Hold
15
– – 0.01% 344
2024
Q2 		$15.8K Buy
15
+6
+67% +$5.82K 0.01% 328
2024
Q1 		$8.66K Hold
9
– – ﹤0.01% 453
2023
Q4 		$7.91K Buy
+9
New +$7.41K ﹤0.01% 468

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Private Wealth Management Group's REGN Position: Q2 2026 in Review

Private Wealth Management Group reduced its Regeneron Pharmaceuticals (REGN) stake by 3.2% in Q2 2026, selling an estimated $1.36K and leaving 60 shares worth $37.4K. The position accounts for 0.01% of the portfolio, ranked #266.

Private Wealth Management Group first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $47.9K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Private Wealth Management Group held 60 shares of Regeneron Pharmaceuticals worth $37.4K as of Q2 2026.
  • Private Wealth Management Group sold 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
  • Regeneron Pharmaceuticals made up 0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #266 holding.
  • Private Wealth Management Group first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Private Wealth Management Group's Regeneron Pharmaceuticals position peaked at $47.9K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.